CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop a new transdermal drug delivery system using biocompatible natural polymers. The innovative design focuses on reducing skin irritation and improving patient compliance with a system that allows easy removal after use.
Current transdermal drug delivery relies primarily upon occlusive patches, and is now considered to be a mature technology.
This method is capable of delivering drugs, reducing side effects of oral administration and poor compliance due to the need for frequent administration.
However, the disadvantages of transdermal delivery systems have been skin irritation, relatively high manufacturing costs and less-than-ideal cosmetic appearance.
Regardless of the transdermal drug delivery system in devel…
UNIVERSITE TOULOUSE III - Paul Sabatier
UNIVERSITE PAUL SABATIER TOULOUSE III
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
